Emildap M 10mg/1000mg Tablet ER
Marketer
Emcure Pharmaceuticals Ltd
Salt Composition
Dapagliflozin (10mg) + Metformin (1000mg)
Overview Emildap M 10mg/1000mg Tablet ER
Diabetic patients with type 2 mellitus may find relief with the extended-release Emildap M 10mg/1000mg tablet, a dual-action medication. This formulation effectively manages elevated blood glucose, lessening the risk of severe diabetic complications and cardiovascular issues. Administered with meals at a consistent daily time, the dosage is determined by your physician and should never be discontinued without their consent; abrupt cessation can lead to dangerously high blood sugar, potentially causing kidney failure or vision impairment. Emildap M is only one component of a comprehensive treatment plan, which must incorporate a doctor-recommended diet, exercise routine, and weight management. Commonly reported side effects include upper respiratory symptoms (sore throat, nasal congestion, rhinorrhea), headache, gastrointestinal upset (nausea, vomiting, diarrhea), and dehydration (mitigated by increased fluid intake). Genital fungal infections are a possibility, preventable through good hygiene. Prior to starting Emildap M, disclose any kidney or liver disease, urinary tract infections, diuretic use, or pregnancy/breastfeeding status to your healthcare provider. Limit alcohol consumption to reduce potential side effects, and consistently monitor your blood sugar levels.
Primary Ingredients of Emildap M 10mg/1000mg Tablet ER
No text provided. Please provide the text you want me to rephrase.
Uses of Emildap M 10mg/1000mg Tablet ER
Managing Type 2 diabetes
Major Benefits of Emildap M 10mg/1000mg Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. The Emildap M 10mg/1000mg Extended-Release tablet should be administered with a meal.
Common Side effects of Emildap M 10mg/1000mg Tablet ER:
- Nausea
- Vomiting
- Diarrhea
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Polyuria
- Flatulence
- Skin rash
- Taste change
- Difficulty in urination
- Hypoglycemia (low blood glucose level)
- Tremors
- Dizziness
- Back pain
- Increased hematocrit
- Decreased creatinine clearance
- Dyslipidemia
How to use Emildap M 10mg/1000mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Emildap M 10mg/1000mg Extended-Release tablet whole; do not chew, crush, or divide it. Administer this medication with a meal.
How Emildap M 10mg/1000mg Tablet ER works:
Emildap M 10mg/1000mg Extended-Release Tablets combine dapagliflozin and metformin to manage type 2 diabetes. Dapagliflozin facilitates glucose excretion via the kidneys, while metformin reduces hepatic glucose production, slows intestinal glucose uptake, and enhances insulin sensitivity. This dual action results in improved glycemic control.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol consumption and Emildap M 10mg/1000mg extended-release tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Extended-release Emildap M tablets (10mg/1000mg) might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Emildap M 10mg/1000mg tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
For individuals with impaired kidney function, the extended-release Emildap M 10mg/1000mg tablet requires careful administration. Dosage modification of Emildap M 10mg/1000mg extended-release tablets may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should use Emildap M 10mg/1000mg Extended-Release tablets cautiously. Dosage modification of Emildap M 10mg/1000mg Extended-Release tablets may be necessary. Physician consultation is advised.
What if you forget to take Emildap M 10mg/1000mg Tablet ER :
Should you forget to take your Emildap M 10mg/1000mg Extended-Release tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Emildap M 10mg/1000mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |





